FDA Inspection 1014881 — Swiss Caps AG

Swiss Caps AG — FEI 3002808292

The FDA completed an inspection of Swiss Caps AG on June 16, 2017 in Kirchberg SG. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 16, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kirchberg SG (Switzerland)

Citations

IDCFRDescription
189021 CFR 211.165(e)Test methods
360321 CFR 211.160(b)Scientifically sound laboratory controls
430521 CFR 211.68(b)Backup data not assured as exact and complete
457621 CFR 211.192No written record of investigation